The immunotherapy, CAN-2409, in combination with radiation therapy, helped 75.2% patients live without any sign of the cancer ...

In most countries, prostate cancer incidence and mortality rates decreased or were stable in the most recent five-year period ...

Dr. Goldberg said that he saw a bump in his P.S.A. levels and received his diagnosis of early-stage prostate cancer in 2022. He began writing a joke book while he was getting treatment. Now he has ...

Hall of Fame second baseman Ryne Sandberg says the prostate cancer he thought had been eliminated by radiation has returned and spread.

Golden Bachelor star Gerry Turner recently shared he received a bone cancer diagnosis prior to filing for divorce from ...

(UroToday.com) The 2024 SUO annual meeting included a prostate cancer session, featuring a debate regarding the management of ...

Published in Nature Communications, a new study led by the University of Minnesota Medical School and Duke University found ...

The new blood-based test — called AR-ctDETECT — is designed to detect and analyze small fragments of tumor-derived DNA in the ...

By Karen Roman Candel Therapeutics, Inc. (Nasdaq: CADL) said Phase 3 of its prostate cancer candidate CAN-2409 showed an upgrade in disease-free survival in intermediate-to-high-risk patients. “We ...

Candel Therapeutics’ viral immunotherapy candidate passed a late-stage test in certain patients with prostate cancer, sending ...

Candel Therapeutics (NASDAQ:CADL) stock rocketed 130% after the company reported positive Phase 3 results for its drug ...

Candel Therapeutics' CAN-2409 shows a 14.5% improvement in prostate cancer survival. Discover why CADL stock stays a "Buy" ...